‌

US Patent 11999738 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors

Patent 11999738 was granted and assigned to Dart Neuroscience Llc on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

Dart Neuroscience Llc

0

Current Assignee

Dart Neuroscience Llc

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

William Francois Vernier0

Laurent Gomez0

Date of Patent

June 4, 2024

0

Patent Application Number

172320150

Date Filed

April 15, 2021

0

Patent Citations

US Patent 8846693 Optionally substituted pyrazolo[3,4-d]pyrimidine-4,6-diones

0

US Patent 8859564 Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione derivatives useful as inhibitors of phosphodiesterase 1

0

US Patent 8927556 1H-pyrrolo[3,4-D]pyrimidin-2(6H)-one compounds

0

US Patent 9023849 Substituted fused imidazoles and pyrazoles and use thereof

0

US Patent 9290511 Thieno-pyrimidines, useful as potassium channel inhibitors

0

US Patent 11434247 Substituted furanopyrimidine compounds as PDE1 inhibitors

0

US Patent 10981916 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors

0

US Patent 7022709 Selective PDE 2 inhibitors as pharmaceuticals for improving perception

0

...

Patent Primary Examiner

Amanda L. Aguirre

0

CPC Code

0

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11999738 Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.